0000000001061273

AUTHOR

Iva Alajbeg

showing 2 related works from this author

Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial

2012

Objective A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would be sustained over an 11-month period. Study Design The device was tested on a mixed sample of 94 patients with xerostomia in an open-label, uncontrolled, prospective multicenter trial. Statutory outcome assessments were done at 5th, 8th, and 11th months and analyzed by multiple comparisons. Results Improvements achieved at month 5 from baseline were sustained throughout the follow-up period for th…

MaleTime FactorsDentistryxerostomia; intraoral saliva electrostimulatorPrimary outcomexerostomia genNarinoMedicineProspective StudiesYoung adultProspective cohort studyLikelihood FunctionsMiddle AgedTreatment OutcomeFemaleOral SurgeryOpen labelAdultSleep Wake DisordersSettore MED/50 - Scienze Tecniche Mediche ApplicateElectric Stimulation TherapyLingual NerveXerostomiaSpeech DisordersXerostomíaNervio lingualPathology and Forensic MedicineSettore MED/01 - Statistica MedicaYoung AdultSwallowingstomatognathic systemSettore MED/28 - Malattie OdontostomatologicheMulticenter trialotorhinolaryngologic diseasesHumansRadiology Nuclear Medicine and imagingDentistry (miscellaneous)SalivaAgedChi-Square Distributionbusiness.industryClinical trialstomatognathic diseasesTherapy Computer-AssistedSurgeryEstimulación eléctrica transcutánea del nerviobusinessDeglutition DisordersSecretory RateChi-squared distributionFollow-Up Studies
researchProduct

Salivary and serum levels of substance p, neurokinin A and calcitonin gene related peptide in burning mouth syndrome

2009

Background: Burning mouth syndrome (BMS) is an enigmatic condition with the etiopathogenesis remaining largely obscure. However, a neuropathic basis for BMS continues to be an area of active clinical and research interest. Aim: It is becoming increasingly evident that certain oral disorders may be modulated by imbalances in certain neuropeptides such as substance P (SP), neurokinin A (NKA) and calcitonin gene-related peptide (CGRP) therefore we measured SP, NKA and CGRP in the saliva and sera of BMS patients as well as controls. Subjects and Methods: Salivary and serum SP, NKA and CGRP were determined in the 26 female patients with burning mouth syndrome (age range 51-78, mean 65.69 yrs), a…

Malemedicine.medical_specialtySalivaCalcitonin Gene-Related PeptideNeurokinin ANeuropeptideSubstance PBurning Mouth SyndromeCalcitonin gene-related peptideSubstance Pchemistry.chemical_compoundInternal medicinemedicineHumansSalivaGeneral DentistryAgedbusiness.industryDopaminergicBurning mouth syndromeMiddle Agedrespiratory system:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesEndocrinologyOtorhinolaryngologychemistryCalcitoninUNESCO::CIENCIAS MÉDICASSubstance P ; neurokinin A ; calcitonin gene-related peptide ; burning mouth syndromeSurgeryFemaleNeurokinin Amedicine.symptombusiness
researchProduct